{"relation": [["", "CP-690,550 5 mg", "CP-690,550 10 mg", "Placebo, Then CP-690,550 5 mg", "Placebo, Then CP-690,550 10 mg", "Total"], ["Description", "CP-690,550 5 milligram (mg) tablet orally twice daily up to Month 6.", "CP-690,550 10 mg tablet orally twice daily up to Month 6.", "Matching placebo tablet orally twice daily up to Month 3 followed by CP-690,550 5 mg tablet twice daily from Month 3 up to Month 6 or early termination.", "Matching placebo tablet orally twice daily up to Month 3 followed by CP-690,550 10 mg tablet twice daily from Month 3 up to Month 6 or early termination.", "Total of all reporting groups"]], "pageTitle": "A Phase 3 Study Comparing 2 Doses of CP-690,550 vs. Placebo for Treatment of Rheumatoid Arthritis - Study Results - ClinicalTrials.gov", "title": "", "url": "https://clinicaltrials.gov/ct2/show/results/NCT00814307?sect=Xq0156&view=results", "hasHeader": true, "headerPosition": "MIXED", "tableType": "RELATION", "tableNum": 6, "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438043060830.93/warc/CC-MAIN-20150728002420-00160-ip-10-236-191-2.ec2.internal.warc.gz", "recordEndOffset": 865061844, "recordOffset": 865045906, "tableOrientation": "HORIZONTAL", "textBeforeTable": "Reporting Groups No text entered. Significant events and approaches for the overall study following participant enrollment, but prior to group assignment Pre-Assignment Details No text entered. Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations Recruitment Details \u00a0 Hide Participant Flow \u00a0 Participant Flow Drug: CP-690,550 Drug: Placebo Interventions: Arthritis, Rheumatoid Condition: Allocation:\u00a0Randomized; \u00a0 Endpoint\u00a0Classification:\u00a0Safety/Efficacy\u00a0Study; \u00a0 Intervention\u00a0Model:\u00a0Parallel\u00a0Assignment; \u00a0 Masking:\u00a0Double\u00a0Blind\u00a0(Subject,\u00a0Caregiver,\u00a0Investigator,\u00a0Outcomes\u00a0Assessor); \u00a0 Primary\u00a0Purpose:\u00a0Treatment Study Design: Interventional Study Type: Results First Received: December 5, 2012 \u00a0", "textAfterTable": "\u00a0 \u00a0 CP-690,550 5 mg \u00a0 \u00a0 CP-690,550 10 mg \u00a0 \u00a0 Placebo, Then CP-690,550 5 mg \u00a0 \u00a0 Placebo, Then CP-690,550 10 mg \u00a0 STARTED \u00a0 \u00a0 244 \u00a0 \u00a0 245 \u00a0 \u00a0 61 \u00a0 \u00a0 61 \u00a0 Treated \u00a0 \u00a0 243 \u00a0 \u00a0 245 \u00a0 \u00a0 61 \u00a0 \u00a0 61 \u00a0 COMPLETED \u00a0 \u00a0 232 \u00a0 \u00a0 218 \u00a0 \u00a0 54 \u00a0 \u00a0 51 \u00a0 NOT COMPLETED \u00a0 \u00a0 12 \u00a0 \u00a0 27 \u00a0 \u00a0 7 \u00a0 \u00a0 10 \u00a0", "hasKeyColumn": false, "keyColumnIndex": -1, "headerRowIndex": 0}